Development of an antibody-dependent cellular cytotoxicity reporter assay for measuring anti-Middle East Respiratory Syndrome antibody bioactivity
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of an antibody-dependent cellular cytotoxicity reporter assay for measuring anti-Middle East Respiratory Syndrome antibody bioactivity
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-06
DOI
10.1038/s41598-020-73960-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate
- (2020) Elisabeth Mahase BMJ-British Medical Journal
- Characterization of a single reporter-gene potency assay for T-cell-dependent bispecific molecules
- (2019) Ho Young Lee et al. mAbs
- Development of a robust reporter gene based assay for the bioactivity determination of IL-5-targeted therapeutic antibodies
- (2018) Zhihao Fu et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape
- (2018) Lingshu Wang et al. JOURNAL OF VIROLOGY
- Structural Definition of a Unique Neutralization Epitope on the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein
- (2018) Senyan Zhang et al. Cell Reports
- Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): A review
- (2018) Sabeena Mustafa et al. Journal of Infection and Public Health
- Measuring the bioactivity of anti-IL-6/anti-IL-6R therapeutic antibodies: presentation of a robust reporter gene assay
- (2018) Chuanfei Yu et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Effector mechanisms of influenza-specific antibodies: neutralization and beyond
- (2018) Federica Sicca et al. Expert Review of Vaccines
- Chimeric camel/human heavy-chain antibodies protect against MERS-CoV infection
- (2018) V. Stalin Raj et al. Science Advances
- A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein is Dependent Upon ADCC for Protection Against Marburg Virus Disease in a Murine Model
- (2018) Rohan Keshwara et al. JOURNAL OF VIROLOGY
- Neutralizing Monoclonal Antibodies as Promising Therapeutics against Middle East Respiratory Syndrome Coronavirus Infection
- (2018) Hui-Ju Han et al. Viruses-Basel
- Development of Small-Molecule MERS-CoV Inhibitors
- (2018) Ruiying Liang et al. Viruses-Basel
- Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever
- (2018) Tiago Abreu-Mota et al. Nature Communications
- Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset
- (2017) Zhe Chen et al. JOURNAL OF INFECTIOUS DISEASES
- A review of candidate therapies for Middle East respiratory syndrome from a molecular perspective
- (2017) Ali A. Rabaan et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Development of a robust reporter gene assay to measure the bioactivity of anti-PD-1/anti-PD-L1 therapeutic antibodies
- (2017) Lan Wang et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Antibody-dependent-cellular-cytotoxicity-inducing antibodies significantly affect the post-exposure treatment of Ebola virus infection
- (2017) Qiang Liu et al. Scientific Reports
- Development of Middle East Respiratory Syndrome Coronavirus vaccines – advances and challenges
- (2017) Heeyoun Cho et al. Human Vaccines & Immunotherapeutics
- A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein
- (2017) Yingzhu Chen et al. Emerging Microbes & Infections
- Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity
- (2017) Luzia M. Mayr et al. Scientific Reports
- Functional advantage of educated KIR2DL1+natural killer cells for anti-HIV-1 antibody-dependent activation
- (2016) S. L. Gooneratne et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- MERS-CoV spike protein: a key target for antivirals
- (2016) Lanying Du et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-Specific Monoclonal Antibodies
- (2016) Benjamin von Bredow et al. JOURNAL OF VIROLOGY
- Coronaviruses — drug discovery and therapeutic options
- (2016) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
- (2016) D. Corti et al. SCIENCE
- 3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012
- (2016) Reed F. Johnson et al. VIROLOGY
- Elimination of HIV-1-infected cells by broadly neutralizing antibodies
- (2016) Timothée Bruel et al. Nature Communications
- A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein
- (2015) Yan Li et al. CELL RESEARCH
- Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus
- (2015) Davide Corti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection
- (2015) Kristen E. Pascal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FcγR dependent mechanisms of cytotoxic, agonistic, and neutralizing antibody activities
- (2015) Falk Nimmerjahn et al. TRENDS IN IMMUNOLOGY
- Evaluation of candidate vaccine approaches for MERS-CoV
- (2015) Lingshu Wang et al. Nature Communications
- Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies
- (2014) Zhijie Jey Cheng et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Characterization of in vitro antibody-dependent cell-mediated cytotoxicity activity of therapeutic antibodies — Impact of effector cells
- (2014) Shan Chung et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies
- (2014) Tianlei Ying et al. JOURNAL OF VIROLOGY
- A Conformation-Dependent Neutralizing Monoclonal Antibody Specifically Targeting Receptor-Binding Domain in Middle East Respiratory Syndrome Coronavirus Spike Protein
- (2014) L. Du et al. JOURNAL OF VIROLOGY
- Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein
- (2014) Jean Kaoru Millet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy
- (2014) A. Hiatt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution
- (2014) X.-C. Tang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
- (2013) Nianshuang Wang et al. CELL RESEARCH
- Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
- (2013) Guangwen Lu et al. NATURE
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
- (2013) V. Stalin Raj et al. NATURE
- Comparative Efficiency of HIV-1-Infected T Cell Killing by NK Cells, Monocytes and Neutrophils
- (2013) Adjoa Smalls-Mantey et al. PLoS One
- A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV
- (2013) Guangyu Zhao et al. Virology Journal
- Development and validation of an antibody-dependent cell-mediated cytotoxicity-reporter gene assay
- (2012) Bhavin S. Parekh et al. mAbs
- Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant
- (2011) L. Zeitlin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting immune effector cells to promote antibody-induced cytotoxicity in cancer immunotherapy
- (2011) Roch Houot et al. TRENDS IN IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now